On a rainy Thursday night in the basement speakeasy of the Colgate Inn, Colgate University students and Hamilton, N.Y., ...

The €50 million ($61 million) deal – in cash and stock – will give Exscientia ownership of a technology platform that takes patient samples and tests them against a library of approved or ...

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults age 45 years and older who are at average risk of colorectal cancer.

Analysts suggest a broader trading range and highlight key support and resistance levels. Several stock recommendations are provided for short-term traders, including Gravita India, Praj Industries, ...

Anita Osborn outlines the best ways to start and maintain a patient support initiative in an increasingly complex health environment. As the healthcare environment continues to evolve, patient ...

This data comes from clinical diagnoses made in A&E, with the true figures varying slightly after patients' samples have been tested. Last year also saw the number of whooping cough diagnoses in A&E ...

After hours: 4 October at 19:26 GMT-4 ...

After hours: 4 October at 7:26 pm GMT-4 ...